hemostats market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

hemostats market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Hemostats Market


The hemostats market size was valued at USD 4.75 billion in 2023, and the market is now projected to grow from USD 5.09 billion in 2024 to USD 9.33 billion by 2032, exhibiting a CAGR of 7.9% during the forecast period of 2023-2030.

COVID- 19 pandemic has tremendously affected the complete world. It affected many unpredicted disturbance and affected the industry. The delay of several surgical treatment resulted in a significant drop in non-essential surgical rates during the original phases of the pandemic.The pandemic caused in declined demand due to a disturbed supply chain, drop in sales of products, delivery lists. The continuous loss in the business projected to directly impact the progress of the investments in the market.

As the number of surgical dealings increases universally, mostly in fields such as cardiovascular, orthopedic, and general surgeries, the demand for hemostats surges. Hemostats play a vital role in managing bleeding during surgical procedure, thus motivating their market growth.An extensive range of medical devices are obtainable for the management and substantial enhancement in attaining hemostasis in surgical dealings.

With more hospitals and surgical centers there's a consistent upsurge in surgical processes performed. The growing number of hospitals and surgical centers universally reflects the rising demand for healthcare services, comprising surgical involvements. There’s a better demand for hemostatic agents to control bleeding during the processes. Technological improvements and innovation motivate unique proceeds augmenting opportunity which will upsurge the hemostats market growth.

Comprehensive Analysis of Hemostats Market

The hemostats market can be segmented in various ways depending on the focus of study such as by end users and by application. Increasing occurrence of cardiovascular diseases demanding surgical interference universally. Based on the application, the market is segmented into trauma, cardiovascular surgery, general surgery, plastic surgery, orthopedic surgery, neurosurgery, and others. By end-user, the market is segmented into hospitals & ASCs, tactical combat casualty care centers, and others.

Asia Pacific region is dominating the hemostats market share due to strong patient population, a considerable upsurge in surgical procedures, and increasing product launches. Strong healthcare expenses that leads to a demand for technologically innovative products due to the durable surgeries volume.

The key players are dynamically contributing in strategic events that are aimed at maintaining strong market position and growing market share by merger, partnerships and others. These players include Baxter (U.S.), Integra LifeSciences (U.S.), Stryker (U.S), Artivion Inc. (U.S.), Biom'up (U.S.), BD (Becton, Dickinson and Company) (U.S.), Medtronic (Ireland), Johnson & Johnson Services, Inc. (U.S.), Pfizer Inc. (U.S.) these market players spending severely on research and development in order to arise with more new technology so that they can maintain and improve their existing market.

In November 2023, Ethicon, a part of the Johnson & Johnson Medical Devices Companies, declared that its ETHIZIA Hemostatic Sealing Patch had acknowledged the CE Mark approval. This product is predictable to be launched in the EMEA region.

Segmentation Table

Attribute Details

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 7.9% from 2024-2032

Unit Value (USD billion)

Segmentation By Product

Active Hemostats

Thrombin Based Hemostats

Fibrin Sealants

Passive Hemostats

Plant-based Hemostats

Animal-based Hemostats

Others

Combination Hemostats

Others

By Application

Trauma

Cardiovascular Surgery

General Surgery

Plastic Surgery

Orthopedic Surgery

Neurosurgery

Others

By End-User

Hospitals & ASCs

Tactical Combat Casualty Care Centers

Others

By Region

North America (By Product, Application, End-User, and Country)

U.S.

Canada

Europe (By Product, Application, End-User, and Country/Sub-region)

U.K.

Germany

France

Italy

Spain

Scandinavia

Rest of Europe

Asia Pacific (By Product, Application, End-User, and Country/Sub-region)

China

Japan

India

Australia & New Zealand

Southeast Asia

Rest of Asia Pacific

Latin America (By Product, Application, End-User, and Country/Sub-region)

Brazil

Mexico

Rest of Latin America

Middle East & Africa (By Product, Application, End-User, and Country/Sub-region)

GCC

South Africa

Rest of Middle East & Africa